Indication
Atopic Dermatitis
The Atopic Dermatitis pipeline: 89 tracked drugs, 11 approved for this indication.
11 approved / phase 415 Phase 340 Phase 25 Phase 1/217 Phase 11 preclinical / unstaged
Compare the share prices of listed companies in Atopic Dermatitis →
Total attributable cost
$207.8B
$10,474/patient
Drug spend
$23.2B
$1,168/patient
11% of total cost is drugs
All severities, self-reported diagnosis (2024 NHIS) · US